The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer

World Journal of Urology

Volumn 32, Issue 4, 2014, Pages 951-958

  Marliere, François ^a   Puech, Philippe ^a   Benkirane, Ahmed ^a   Villers, Arnauld ^a,b   Lemaitre, Laurent ^a,b   Leroy, Xavier ^a   Betrouni, Nacim ^b   Ouzzane, Adil ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Biopsy; Diagnosis; Magnetic resonance imaging; Prostatic neoplasm; Watchful waiting

Indexed keywords

AGED; BIOPSY; CANCER GRADING; CANCER STAGING; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT SELECTION; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PATIENT SELECTION; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84904987996     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-014-1314-5     Document Type: Article

References (19)

1. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Paez A, Maattanen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A (2012) Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 366(11): 981-990. doi: 10. 1056/NEJMoa1113135.
2. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A (2010) A clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28(1): 126-131. doi: 10. 1200/JCO. 2009. 24. 2180.
3. Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, Tempany CM (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37(5): 1035-1054. doi: 10. 1002/jmri. 23860.
4. Haffner J, Lemaitre L, Puech P, Haber GP, Leroy X, Jones JS, Villers A (2011) Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 108(8 Pt 2): E171-E178. doi: 10. 1111/j. 1464-410X. 2011. 10112. x.
5. Ouzzane A, Puech P, Lemaitre L, Leroy X, Nevoux P, Betrouni N, Haber GP, Villers A (2011) Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. Urology 78(6): 1356-1362. doi: 10. 1016/j. urology. 2011. 06. 022.
6. Puech P, Potiron E, Lemaitre L, Leroy C, Biserte J, Villers A (2009) Dynamic contrast-enhanced MRI evaluation of intraprostatic prostate cancer. Correlation with radical prostatectomy specimens. Urology 74(5): 1094-1099. doi: 10. 1016/j. urology. 2009. 04. 102.
7. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin PJ, Kirkham A, Padhani AR, Persad R, Puech P, Punwani S, Sohaib AS, Tombal B, Villers A, van der Meulen J, Emberton M (2011) Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59(4): 477-494. doi: 10. 1016/j. eururo. 2010. 12. 009.
8. Puech P, Rouviere O, Renard-Penna R, Villers A, Devos P, Colombel M, Bitker MO, Leroy X, Mege-Lechevallier F, Comperat E, Ouzzane A, Lemaitre L (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-prospective multicenter study. Radiology 268(2): 461-469. doi: 10. 1148/radiol. 13121501.
9. Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR (2011) Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol 29(20): 2795-2800. doi: 10. 1200/JCO. 2010. 33. 0134.
10. Lee MC, Dong F, Stephenson AJ, Jones JS, Magi-Galluzzi C, Klein EA (2009) The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy. Eur Urol 58(1): 90-95. doi: 10. 1016/j. eururo. 2009. 10. 025.
11. Shapiro RH, Johnstone PA (2012) Risk of Gleason grade inaccuracies in prostate cancer patients eligible for active surveillance. Urology 80(3): 661-666. doi: 10. 1016/j. urology. 2012. 06. 022.
12. Crawford ED, Wilson SS, Torkko KC, Hirano D, Stewart JS, Brammell C, Wilson RS, Kawata N, Sullivan H, Lucia MS, Werahera PN (2005) Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int 96(7): 999-1004. doi: 10. 1111/j. 1464-410X. 2005. 05801. x.
13. Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD (2008) Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol 180(5): 1964-1967. doi: 10. 1016/j. juro. 2008. 07. 051 (discussion 1967-1968).
14. Margel D, Yap SA, Lawrentschuk N, Klotz L, Haider M, Hersey K, Finelli A, Zlotta A, Trachtenberg J, Fleshner N (2012) Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study. J Urol 187(4): 1247-1252. doi: 10. 1016/j. juro. 2011. 11. 112.
15. Bott SR, Young MP, Kellett MJ, Parkinson MC (2002) Anterior prostate cancer: is it more difficult to diagnose? BJU Int 89(9): 886-889.
16. Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013) Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268(1): 144-152. doi: 10. 1148/radiol. 13121325.
17. Mullins JK, Bonekamp D, Landis P, Begum H, Partin AW, Epstein JI, Carter HB, Macura KJ (2013) Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU Int 111(7): 1037-1045. doi: 10. 1111/j. 1464-410X. 2012. 11641. x.
18. Borofsky MS, Rosenkrantz AB, Abraham N, Jain R, Taneja SS (2013) Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy? Urology 81(6): 1279-1283. doi: 10. 1016/j. urology. 2012. 12. 026.
19. Shukla-Dave A, Hricak H, Akin O, Yu C, Zakian KL, Udo K, Scardino PT, Eastham J, Kattan MW (2012) Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 109(9): 1315-1322. doi: 10. 1111/j. 1464-410X. 2011. 10612. x.